Robert G. Finizio
Net Worth

Last updated:

What is Robert G. Finizio net worth?

The estimated net worth of Mr. Robert G. Finizio is at least $33,461,122 as of 11 May 2021. He owns shares worth $19,970,717 as insider, has earned $70,405 from insider trading and has received compensation worth at least $13,420,000 in TherapeuticsMD, Inc..

What is the salary of Robert G. Finizio?

Mr. Robert G. Finizio salary is $1,220,000 per year as Co-Founder & Vice Chair in TherapeuticsMD, Inc..

How old is Robert G. Finizio?

Mr. Robert G. Finizio is 54 years old, born in 1971.

What stocks does Robert G. Finizio currently own?

As insider, Mr. Robert G. Finizio owns shares in one company:

Company Title Shares Price per share Total value
TherapeuticsMD, Inc. (TXMD) Co-Founder & Vice Chair 17,991,637 $1.11 $19,970,717

What does TherapeuticsMD, Inc. do?

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TXMD logo
TXMD
TherapeuticsMD, Inc.
$1.11

Robert G. Finizio insider trading

TherapeuticsMD, Inc.

Mr. Robert G. Finizio has made 24 insider trades between 2014-2021, according to the Form 4 filled with the SEC. Most recently he sold 67,697 units of TXMD stock worth $70,405 on 11 May 2021.

The largest trade he's ever made was exercising 982,053 units of TXMD stock on 26 Mar 2014. As of 11 May 2021 he still owns at least 17,991,637 units of TXMD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 67,697 $1.04 $70,405
Option
Common Stock 158,334 N/A N/A
Option
Restricted Stock Units 158,334 N/A N/A
Purchase
Common Stock 46,000 N/A N/A
Purchase
Common Stock 46,000 $1.44 $66,240
Purchase
Common Stock 30,000 N/A N/A
Purchase
Common Stock 30,000 $1.16 $34,650
Purchase
Common Stock 72,000 N/A N/A
Purchase
Common Stock 35,000 N/A N/A
Purchase
Common Stock 52,405 N/A N/A
Option
Common Stock 92,910 N/A N/A
Sale
Common Stock 92,910 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,910 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Common Stock 92,000 N/A N/A
Option
Non-Qualified Stock Option (right to buy) 92,000 N/A N/A
Sale
Common Stock 92,000 N/A N/A
Option
Common Stock 31,526 N/A N/A
Option
Non-qualified Stock Option (right to buy) 31,526 N/A N/A
Sale
Common Stock 982,053 N/A N/A
Sale
Common Stock 16,600 N/A N/A
Sale
Common Stock 16,700 N/A N/A
Sale
Common Stock 16,700 N/A N/A
Sale
Common Stock 16,600 N/A N/A
Sale
Common Stock 16,700 N/A N/A
Sale
Common Stock 16,700 N/A N/A

TherapeuticsMD key executives

TherapeuticsMD, Inc. executives and other stock owners filed with the SEC: